Cargando…
Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer
Epigenetic silencing of miRNA is a primary mechanism of aberrant miRNA expression in cancer, and hypermethylation of miRNA promoters has been reported to contribute to prostate cancer initiation and progression. Recent data have shown that the miR‐193b promoter is hypermethylated in prostate cancer...
Autores principales: | Mazzu, Ying Z., Yoshikawa, Yuki, Nandakumar, Subhiksha, Chakraborty, Goutam, Armenia, Joshua, Jehane, Lina E., Lee, Gwo‐Shu Mary, Kantoff, Philip W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717747/ https://www.ncbi.nlm.nih.gov/pubmed/31225930 http://dx.doi.org/10.1002/1878-0261.12536 |
Ejemplares similares
-
Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
por: Mazzu, Ying Z., et al.
Publicado: (2020) -
Increased
MYBL2
expression in aggressive hormone‐sensitive prostate cancer
por: Yoshikawa, Yuki, et al.
Publicado: (2022) -
Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer
por: Mazzu, Ying Z., et al.
Publicado: (2022) -
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity
por: Mazzu, Ying Z., et al.
Publicado: (2022) -
N(6)-Methyladenosine Associated Silencing of miR-193b Promotes Cervical Cancer Aggressiveness by Targeting CCND1
por: Huang, Chunxian, et al.
Publicado: (2021)